Dave J. Pfanzelter

2017

In 2017, Dave J. Pfanzelter earned a total compensation of $1.7M as Chairman of the Board at PURE Bioscience, a 604% increase compared to previous year.

Compensation breakdown

Option Awards$972,000
Salary$150,000
Stock Awards$595,000
Total$1,717,000

Pfanzelter received $972K in option awards, accounting for 57% of the total pay in 2017.

Pfanzelter also received $150K in salary and $595K in stock awards.

Rankings

In 2017, Dave J. Pfanzelter's compensation ranked 6,272nd out of 14,666 executives tracked by ExecPay. In other words, Pfanzelter earned more than 57.2% of executives.

ClassificationRankingPercentile
All
6,272
out of 14,666
57th
Division
Manufacturing
2,308
out of 5,768
60th
Major group
Chemicals And Allied Products
732
out of 2,074
65th
Industry group
Miscellaneous Chemical Products
12
out of 32
63rd
Source: SEC filing on December 8, 2017.

Pfanzelter's colleagues

We found two more compensation records of executives who worked with Dave J. Pfanzelter at PURE Bioscience in 2017.

2017

Henry Lambert

PURE Bioscience

Chief Executive Officer

2017

Mark Elliott

PURE Bioscience

Vice President Finance

News

In-depth

You may also like